https://doi.org/10.1186/s13046-019-1284-y
H
Hongqiang Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
81
Papers
1.2K
Citations
18
h-index
23
i10-index
Hongqiang Wang is an academic researcher from Qingdao University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer, Hypoxia, and Metabolism & Gene expression and cancer classification. The author has an h-index of 18, co-authored 69 publications.
ORCID: 0000-0003-1885-7611Papers by this author
worksHERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway
2019 · Journal of Experimental & Clinical Cancer Research · 37 citations
Specific inhibition of PI3Kδ/γ enhances the efficacy of anti-PD1 against osteosarcoma cancer
2018 · Journal of bone oncology · 27 citations
https://doi.org/10.1016/j.jbo.2018.11.001
Activated T cell therapy targeting glioblastoma cancer stem cells
2023 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-022-27184-w
Lycopene inhibits apoptosis of mouse spermatocytes in varicocele via miR-23a/b-induced downregulation of PROK2
2024 · Reproduction Fertility and Development · 5 citations
https://doi.org/10.1071/rd23136
Adaptively capturing the heterogeneity of expression for cancer biomarker identification
2018 · BMC Bioinformatics · 4 citations
https://doi.org/10.1186/s12859-018-2437-2
296 Towards Nose-to-brain Inhibition of NFB: Activity of a Novel p65 Inhibitor in Glioblastoma and Feasibility of Intranasal Delivery With a Near-infrared Fluorescent HMC-Chitosan Nanoparticle
2024 · Neurosurgery · 0 citations
https://doi.org/10.1227/neu.0000000000002809_296
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat